Home › Regeneron skids on shortfall in Eylea sales
 

Keywords :   


Regeneron skids on shortfall in Eylea sales

2014-11-05 00:27:56| Biotech - Topix.net

Regeneron Pharmaceuticals Inc. tumbled by more than $21 a share in morning trade Tuesday after the drug maker surprised investors with disappointing sales of a key product and reported third-quarter earnings that fell below forecasts. stumbled from grace as analysts said some of the air appears to be seeping from expectations for the company's blockbuster eye drug, Eylea.

Tags: sales shortfall skids regeneron

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Graphics
02.11Tropical Storm Lane Wind Speed Probabilities Number 5
02.11Tropical Storm Lane Forecast Advisory Number 5
02.11Tropical Storm Lane Public Advisory Number 5
02.11Summary for Tropical Storm Lane (EP3/EP132024)
02.11Subtropical Storm Patty Forecast Discussion Number 3
02.11Subtropical Storm Patty Wind Speed Probabilities Number 3
More »